100 related articles for article (PubMed ID: 8623836)
1. Evidence for a unifocal origin in familial ovarian cancer.
Gallion HH; Guarino A; DePriest PD; van Nagell JR; Vaccarello L; Berek JS; Pieretti M
Am J Obstet Gynecol; 1996 Apr; 174(4):1102-6; discussion 1106-8. PubMed ID: 8623836
[TBL] [Abstract][Full Text] [Related]
2. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
Lee JH; Kavanagh JJ; Wildrick DM; Wharton JT; Blick M
Cancer Res; 1990 May; 50(9):2724-8. PubMed ID: 2328498
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic changes associated with ovarian cancer.
Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
[TBL] [Abstract][Full Text] [Related]
4. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA
Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
Lu KH; Bell DA; Welch WR; Berkowitz RS; Mok SC
Cancer Res; 1998 Jun; 58(11):2328-30. PubMed ID: 9622067
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors.
Wertheim I; Tangir J; Muto MG; Welch WR; Berkowitz RS; Chen WY; Mok SC
Oncogene; 1996 May; 12(10):2147-53. PubMed ID: 8668340
[TBL] [Abstract][Full Text] [Related]
7. Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer.
Yang-Feng TL; Li S; Han H; Schwartz PE
Int J Cancer; 1992 Oct; 52(4):575-80. PubMed ID: 1399139
[TBL] [Abstract][Full Text] [Related]
8. Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group.
Eccles DM; Russell SE; Haites NE; Atkinson R; Bell DW; Gruber L; Hickey I; Kelly K; Kitchener H; Leonard R
Oncogene; 1992 Oct; 7(10):2069-72. PubMed ID: 1408149
[TBL] [Abstract][Full Text] [Related]
9. Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.
Jacobs IJ; Kohler MF; Wiseman RW; Marks JR; Whitaker R; Kerns BA; Humphrey P; Berchuck A; Ponder BA; Bast RC
J Natl Cancer Inst; 1992 Dec; 84(23):1793-8. PubMed ID: 1433368
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancer.
Schildkraut JM; Collins NK; Dent GA; Tucker JA; Barrett JC; Berchuck A; Boyd J
Am J Obstet Gynecol; 1995 Mar; 172(3):908-13. PubMed ID: 7892884
[TBL] [Abstract][Full Text] [Related]
11. Polymerase chain reaction allelotyping of human ovarian cancer.
Osborne RJ; Leech V
Br J Cancer; 1994 Mar; 69(3):429-38. PubMed ID: 8123469
[TBL] [Abstract][Full Text] [Related]
12. Advanced ovarian carcinoma: molecular evidence of unifocal origin.
Li S; Han H; Resnik E; Carcangiu ML; Schwartz PE; Yang-Feng TL
Gynecol Oncol; 1993 Oct; 51(1):21-5. PubMed ID: 8244169
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas.
Tsao SW; Mok CH; Knapp RC; Oike K; Muto MG; Welch WR; Goodman HM; Sheets EE; Berkowitz RS; Lau CC
Gynecol Oncol; 1993 Jan; 48(1):5-10. PubMed ID: 8423021
[TBL] [Abstract][Full Text] [Related]
14. Allelic deletion mapping of putative tumor suppressor genes on 17q in sporadic ovarian cancer.
Chen KC; Hsieh TT; Schwartz PE; Yang-Feng TL
J Obstet Gynaecol (Tokyo 1995); 1995 Dec; 21(6):619-24. PubMed ID: 8640474
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas.
Sano T; Tsujino T; Yoshida K; Nakayama H; Haruma K; Ito H; Nakamura Y; Kajiyama G; Tahara E
Cancer Res; 1991 Jun; 51(11):2926-31. PubMed ID: 2032230
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.
Thorlacius S; Jonasdottir O; Eyfjord JE
Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906
[TBL] [Abstract][Full Text] [Related]
17. Whole chromosome 17 loss in ovarian cancer.
Tavassoli M; Ruhrberg C; Beaumont V; Reynolds K; Kirkham N; Collins WP; Farzaneh F
Genes Chromosomes Cancer; 1993 Nov; 8(3):195-8. PubMed ID: 7509629
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.
Gao X; Zacharek A; Salkowski A; Grignon DJ; Sakr W; Porter AT; Honn KV
Cancer Res; 1995 Mar; 55(5):1002-5. PubMed ID: 7866981
[TBL] [Abstract][Full Text] [Related]
19. Allele loss at the c-Ha-ras1 locus in human ovarian cancer.
Lee JH; Kavanagh JJ; Wharton JT; Wildrick DM; Blick M
Cancer Res; 1989 Mar; 49(5):1220-2. PubMed ID: 2917352
[TBL] [Abstract][Full Text] [Related]
20. Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: intratumoral molecular heterogeneity.
Zborovskaya I; Gasparian A; Karseladze A; Elcheva I; Trofimova E; Driouch K; Trassard M; Tatosyan A; Lidereau R
Int J Cancer; 1999 Sep; 82(6):822-6. PubMed ID: 10446448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
